Efficacy of 810-nm diode laser transpupillary thermotherapy delivered using the methodology developed for small (T1) choroidal melanomas
Journal Title: Офтальмологический журнал - Year 2019, Vol 0, Issue 3
Abstract
Background: Diode laser transpupillary thermotherapy (TTT) used as a monotherapy may be a treatment of choice for small choroidal melanomas (CM). We developed the methodology for performing TTT, which involves four sessions delivered daily over four consecutive days (Information Bulletin No. 22, based on Pat. of Ukraine №102,890 issued 25.11.2015. Method for treatment of T1 choroidal melanoma), and which we have been using for the treatment of small (T1) CM (measuring ≤ 3 mm in thickness and ≤ 12 mm in basal dimension) for 15 years. Purpose: To assess the efficacy of 810-nm diode laser TTT delivered using the developed methodology in small tumors differing in magnitude of baseline characteristics. Materials and Methods: We assessed the efficacy of 810-nm diode laser TTT delivered using the developed methodology for the small (T1) CM (measuring ≤ 3 mm in protrusion into the vitreous and ≤ 12 mm in basal dimension). Eighty-eight patients (63 men (71.6%) and 25 women (28.4%); mean age, 55.9 (12.8) years (range, 23 to 82 years) with small (T1) CM were involved into the study. The right eye was affected in 41 cases (46.6%), and the left eye was affected in the other 47 cases (53.4%). At baseline, no patient had metastasis. Treatment outcome was categorized as positive if partial or complete scarring of the tumor site was observed or negative if tumor growth persisted. Results: Eighty-one patient (92.05%) reached a positive treatment outcome, and 7 (7.95%) had a negative treatment outcome. In addition, complete scarring or partial scarring was found in 81.5% and 18.5%, respectively, of those with a positive treatment outcome. The treatment outcome in patients even with small (T1) CM (measuring ≤ 3 mm in thickness and ≤ 12 mm in basal dimension) depended on tumor dimensions and tumor area at baseline. Patients with small CM of more than 2.18-mm protrusion into the vitreous, more than 8.45-mm basal dimension, and more than 66.6 mm2 tumor area were 2.80 times more likely to have a negative treatment outcome. Conclusion: We developed the methodology for performing TTT, which involves four sessions delivered daily over four consecutive days (Information Bulletin No. 22, based on Pat. of Ukraine №102,890 issued 25.11.2015. Method for treatment of T1 choroidal melanoma) for the treatment of small (T1) CM (measuring ≤ 3 mm in thickness and ≤ 12 mm in basal dimension). The success rate of the TTT methodology developed for small (T1) CM (measuring ≤ 3 mm in thickness and ≤ 12 mm in basal dimension) was 92.05%. The efficacy of treatment of small (T1) CM depended on tumor parameters at baseline: patients with a small CM measuring < 2 mm in thickness, < 8 mm in basal dimension, and < 66 m2 in area were more likely to have a positive treatment outcome in the form of scarring of the tumor site in 81.5% of cases.
Authors and Affiliations
I. Tsukanova, S. Poliakova, V. A. Naumenko, N. Pasyechnikova
Changes over treatment in total clinical symptom scores in patients with traumatic keratitis
ackground: Since corneal tissue hypoxia develops in patients with traumatic keratitis, investigation of changes over treatment in clinical symptom scores in patients with traumatic keratitis undergoing adjunctive hyperb...
Speed of development and speed of progression of primary open-angle glaucoma
Purpose: To perform the analysis of the results of primary open-angle glaucoma (POAG) patients’ examination at presentation and to build objective criteria for the development and progression of the disease. Materials a...
Infrared thermography of external ocular surface in patients with absolute glaucoma in transscleral cyclophotocoagulation: a pilot study
Background: Changes in the temperature of external ocular surface in patients with absolute neovascular glaucoma (including the changes after transscleral contact cyclophotocoagulation with scleral compression (TCCSC)) a...
Clinical efficacy of treatment for subclinical-stage axial diabetic optic neuropathy
Background: There is no standard of therapy for the treatment of diabetic optic neuropathy (DON). Purpose: To assess the clinical efficacy of thioctic acid, topical brimonidine tartrate and a combination of vitamins В1,...
Nadezhda A. Puchkovskaia (110th Birth Anniversary)
Nadezhda A. Puchkovskaia, an academician of the National Academy of Science and National Academy of Medical Science of Ukraine, Academy of Medical Science of RF, International Academy of Ophthalmology, Honorable member o...